Pharmaceuticals & Manufacturing

Thumbnail for Eli Lilly invests up to US$630M in OliX’s RNAi-based MASH drug

14 February 2025

Eli Lilly invests up to US$630M in OliX’s RNAi-based MASH drug

Thumbnail for Abcuro lands US$200M to advance IBM therapy

14 February 2025

Abcuro lands US$200M to advance IBM therapy

Thumbnail for Genentech’s Evrysdi gets FDA nod in tablet form

13 February 2025

Genentech’s Evrysdi gets FDA nod in tablet form

Thumbnail for Novartis to acquire Anthos Therapeutics for US$925M

13 February 2025

Novartis to acquire Anthos Therapeutics for US$925M

Thumbnail for Sanofi to localize insulin production in Saudi Arabia

12 February 2025

Sanofi to localize insulin production in Saudi Arabia

Thumbnail for Novo Nordisk plans new Phase III trial to strengthen CagriSema’s efficacy data

11 February 2025

Novo Nordisk plans new Phase III trial to strengthen CagriSema’s efficacy data

Thumbnail for EVA Pharma, DNA Script, and Quantoom Biosciences collaboratae to launch African mRNA platform

11 February 2025

EVA Pharma, DNA Script, and Quantoom Biosciences collaboratae to launch African mRNA platform

Thumbnail for Daewoong’s Nabota launches in Saudi Arabia

11 February 2025

Daewoong’s Nabota launches in Saudi Arabia

Thumbnail for Bain Capital acquires Mitsubishi Tanabe Pharma in US$3.4B deal

11 February 2025

Bain Capital acquires Mitsubishi Tanabe Pharma in US$3.4B deal

Thumbnail for AbbVie’s Emblaveo approved for cIAI in patients with limited treatment options

11 February 2025

AbbVie’s Emblaveo approved for cIAI in patients with limited treatment options